Exercise for Cardiovascular Disease Prevention and Treatment From Molecular to Clinical, Part 1

(Elle) #1

216


modulates multiple redox-sensitive proteins and signaling pathways [ 131 ]. The


interaction between cytochrome b558 and the cytosolic components of NADPH


oxidase generates O 2 • through catalyzing the transfer of electrons to molecular oxy-


gen [ 110 ] (Fig. 12.3). Therefore, increased expression and activation of NOXs have


been reported in animal models of type 1 and type 2 DM [ 114 , 132 ] and were asso-


ciated with the pathogenesis of diabetes-associated vascular disease [ 133 ]. In this


context, rats with left ventricular hypertrophy (LVH) [ 134 ] and human diabetic


patients with cardiomyopathy [ 135 ] showed increased activity and expression of


NOXs. In guinea pig with LVH, NOX-dependent O 2 • production and expression of


NOX2 were significantly increased in the cardiomyocytes [ 136 ]. Overexpression of


NOX4 increased O 2 • generation, cardiac dysfunction and apoptosis of cardiac cells


[ 137 ]. Recently, Sharma et al. [ 138 ] demonstrated that STZ-induced diabetes in rats


significantly increased left ventricular p47phox and p67phox both mRNA and pro-


tein expression.


Studies on the genetic and pharmacological inhibition of NOXs have further

highlighted the role of these ROS-generating enzymes in mediating cardiomyopa-


thy. In type 1 diabetic mice, the inhibition of NOX2 reduced myocardial fibrosis and


improved cardiac function [ 139 ]. Treatment of type 2 diabetic rodents with angio-


tensin receptor blocker reduced NOX2 expression, ROS production and fibrosis of


cardiomyocytes [ 114 , 132 ]. Specific deletion of rac1, a cytosolic component of


many NOX isoforms, in cardiomyocytes significantly reduced hyperglycemia-


induced myocardial dysfunction, up-regulation of NADPH oxidase activity, ROS


generation and cardiomyocyte apoptosis [ 140 ]. The hyperglycemic db/db mice


exhibited marked inhibition of cardiomyocyte NADPH oxidase activity and apopto-


sis following treatment with a rac1 inhibitor [ 140 ]. Collectively, these data show the


critical contribution of NADPH oxidase-dependent ROS production in DCM.


The effect of exercise training on the expression and activity of NADPH oxidase

in the diabetic myocardium has been demonstrated in several studies. Grijalva et al.


[ 141 ] reported a significant reduction in NOX2 activity in the myocardium of type


Fig. 12.3 Components of NADPH oxidase


A.M. Mahmoud
Free download pdf